Substituted cyclopentanes or cyclopentanones for the treatment of ocular hypertensive conditions

Details for Australian Patent Application No. 2006205029 (hide)

Owner Allergan, Inc.

Inventors Old, David W.; Ngo, Vinh X.; Gac, Todd S.

Agent Davies Collison Cave

Pub. Number AU-B-2006205029

PCT Pub. Number WO2006/076370

Priority 60/644,069 14.01.05 US

Filing date 10 January 2006

Wipo publication date 20 July 2006

Acceptance publication date 6 September 2012

International Classifications

C07C 59/68 Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O-metal, CHO, keto, ether, groups, groups, or groups

A61K 31/192

A61K 31/222

A61P 27/06 Drugs for disorders of the senses

C07C 59/90 Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O-metal, CHO, keto, ether, groups, groups, or groups

C07C 69/02 Esters of carboxylic acids

C07C 69/52 Esters of carboxylic acids

Event Publications

2 August 2007 PCT application entered the National Phase

  PCT publication WO2006/076370 Priority application(s): WO2006/076370

6 September 2012 Application Accepted

  Published as AU-B-2006205029

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006205031-Trailer mounted attenuator with breakaway axle assembly

2006205025-Method and system for displaying blood flow